Sphera Funds Management Ltd. Astria Therapeutics, Inc. Transaction History
Sphera Funds Management Ltd.
- $486 Million
- Q4 2024
A detailed history of Sphera Funds Management Ltd. transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 139,800 shares of ATXS stock, worth $858,372. This represents 0.25% of its overall portfolio holdings.
Number of Shares
139,800
Previous 136,582
2.36%
Holding current value
$858,372
Previous $1.5 Million
18.1%
% of portfolio
0.25%
Previous 0.28%
Shares
9 transactions
Others Institutions Holding ATXS
# of Institutions
115Shares Held
50.3MCall Options Held
75KPut Options Held
6.2K-
Perceptive Advisors LLC New York, NY6.49MShares$39.8 Million1.91% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.11MShares$31.3 Million0.73% of portfolio
-
Vestal Point Capital, LP New York, NY4.18MShares$25.7 Million2.22% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$21.8 Million6.29% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$21.6 Million0.0% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $93.2M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...